PSA Semi-Quantitative Rapid Test Device (WB/S/P)

PSA semi-quantitative testing helps detect and estimate Prostate Specific Antigen levels in whole blood, serum, or plasma. PSA is a protein produced by normal and abnormal prostate cells. PSA levels may rise due to prostate cancer as well as non-cancerous conditions such as benign prostate enlargement, inflammation, or infection.

• The PSA semi-quantitative rapid test helps support early prostate health assessment.
• Prostate conditions may not show clear symptoms in the early stage, making PSA screening useful in professional healthcare workflows.
• The test helps estimate PSA level ranges instead of only showing positive or negative results.
• Raised PSA levels should always be reviewed by healthcare professionals because PSA may increase due to age, enlarged prostate, inflammation, infection, or prostate cancer risk.

The PSA Semi-Quantitative Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and men’s health screening environments.

Applications

• Prostate health screening
• Men’s preventive health checkups
• Urology clinic evaluation
• Elevated PSA risk assessment
• Follow-up testing guidance
• Point-of-care testing workflows
• Tumor marker screening programs
• Diagnostic laboratory evaluation
• International diagnostic distribution

• The PSA Semi-Quantitative Rapid Test Device works through a lateral flow immunoassay method.
• A whole blood, serum, or plasma sample is added to the test device.
• PSA in the sample reacts with PSA-specific antibodies and migrates along the membrane.
• Depending on PSA concentration, visible test lines appear according to the product instructions.

The PSA Semi-Quantitative Rapid Test Device uses rapid lateral flow immunochromatographic technology for semi-quantitative detection of Prostate Specific Antigen in whole blood, serum, or plasma specimens.

Benefits

• Rapid PSA detection
• Semi-quantitative result support
• Suitable for whole blood, serum, or plasma
• Simple visual interpretation
• Professional diagnostic application
• Supports urology and men’s health programs
• Practical point-of-care format
• No major instrument required

The PSA Semi-Quantitative Rapid Test Device is designed for whole blood, serum, or plasma specimens. Proper specimen collection and handling are important for reliable test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean sample collection materials
• Avoid contaminated or improperly stored samples
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The PSA Semi-Quantitative Rapid Test Device by LARKSOIS Pharma is designed to detect and estimate Prostate Specific Antigen levels in whole blood, serum, or plasma specimens. It helps healthcare professionals screen PSA levels quickly before further laboratory confirmation.

• PSA testing may support prostate health screening and elevated PSA assessment.
• A raised PSA level does not always mean cancer and may occur due to age, enlarged prostate, inflammation, infection, or recent prostate-related procedures.
• Healthcare professionals should interpret PSA results with clinical history, physical examination, age, and confirmatory testing.
• The test may support urology clinics, men’s health programs, diagnostic laboratories, and screening camps.

The PSA Semi-Quantitative Rapid Test Device is a screening aid and should not be used alone to confirm prostate cancer. Results should be interpreted with age, symptoms, clinical history, examination findings, and confirmatory laboratory testing.

Instructions

• The test does not confirm prostate cancer on its own
• Elevated PSA may occur due to non-cancerous prostate conditions
• Incorrect specimen handling may affect results
• False positive or false negative results may occur
• Recent prostate procedures may affect PSA levels
• Results should be interpreted with clinical findings
• Additional laboratory testing may be required
• Follow the official product insert carefully

Instructions

• Rapid PSA detection
• Semi-quantitative result support
• Suitable for whole blood, serum, or plasma
• Simple rapid test procedure
• Useful for prostate health screening
• Professional diagnostic application
• Supports urology and men’s health programs
• Practical point-of-care format

Note

The PSA Semi-Quantitative Rapid Test Device by LARKSOIS Pharma is developed for professional users who need practical and accessible prostate screening support.

Steps

• Bring the test device, sample, and buffer to room temperature
• Remove the cassette from the sealed pouch
• Place it on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed
• Wait for the recommended reaction time
• Read test and control lines within the valid time window
• Compare results according to the semi-quantitative guide in the product insert
• Do not read results after the recommended time
• Dispose of used materials according to laboratory safety rules

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

Elevated PSA range may indicate prostate enlargement, inflammation, infection, or prostate cancer risk. Further medical evaluation may be required.

Negative

Lower PSA range may indicate PSA is within the expected range, depending on age and clinical background.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device according to the product insert.

Instructions

• Store the PSA Semi-Quantitative Rapid Test Device according to the label and product insert
• Store in a dry place
• Keep sealed until use
• Protect from moisture
• Avoid direct sunlight
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood samples as potentially infectious
• Wear gloves during sample handling
• Do not reuse the test cassette
• Avoid specimen cross-contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm results with clinical evaluation when required

LARKSOIS Pharma provides professional rapid diagnostic products for international healthcare markets. The PSA Semi-Quantitative Rapid Test Device reflects the company’s focus on quality, usability, and accessible diagnostic support for prostate health screening.

Advantages

• International tumor marker diagnostic range
• Export-ready rapid test portfolio
• Professional healthcare quality focus
• Suitable for hospitals and laboratories
• Practical point-of-care test format
• Reliable product support for distributors
• Strong focus on global diagnostic accessibility